上海信裕生物科技有限公司
中級會員 | 第12年

15221858802

當前位置:上海信裕生物科技有限公司>>抗體>>一抗>> ZNHIT3蛋白抗體

ZNHIT3蛋白抗體

參   考   價: 80

訂  貨  量: ≥1 

具體成交價以合同協(xié)議為準

產(chǎn)品型號

品       牌Abcam

廠商性質(zhì)生產(chǎn)商

所  在  地上海

更新時間:2015-06-04 14:45:27瀏覽次數(shù):238次

聯(lián)系我時,請告知來自 化工儀器網(wǎng)
同類優(yōu)質(zhì)產(chǎn)品更多>
ZNHIT3蛋白抗體
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復)
not yet tested in other applications.

ZNHIT3蛋白抗體

英文名稱 ZNHIT3
中文名稱 ZNHIT3蛋白抗體
別    名 HNF 4a coactivator; Thyroid hormone receptor interactor 3; Thyroid receptor interacting protein 3; TR interacting protein 3; TRIP 3; ZNHI3_HUMAN; TRIP3; Zinc finger HIT domain containing protein 3; Zinc finger HIT type 3; Zinc finger, HIT domain containing 3; Zinc finger, HIT type containing 3.

說 明 書 0.2ml  
研究領(lǐng)域 細胞生物  轉(zhuǎn)錄調(diào)節(jié)因子  鋅指蛋白  表觀遺傳學  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應 Human, Mouse, Rat, Rabbit, 
產(chǎn)品應用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復) 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 18kDa
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human ZNHIT3
亞    型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4℃.

PubMed PubMed
產(chǎn)品介紹 background:
ZNHIT3 is a 155 amino acid protein that contains one HIT-type zinc finger and regulates PPAR?mediated adipocyte differentiation. ZNHIT3 also coactivates HNF-4? and as a thyroid receptor interacting protein, ZNHIT3 interacts with the ligand binding domain of the thyroid receptor. The gene encoding ZNHIT3 maps to human chromosome 17, which comprises over 2.5% of the human genome and encodes over 1,200 genes. Two key tumor suppressor genes are associated with chromosome 17, namely, p53 and BRCA1. Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome. Like p53, BRCA1 is directly involved in DNA repair, though specifically it is recognized as a genetic determinant of early onset breast cancer and predisposition to cancers of the ovary, colon, prostate gland and fallopian tubes.

Function:
ZNHIT3 functions as a transcriptional coactivator and contains 1 HIT type zinc finger.

Subunit:
Thyroid receptor interacting proteins (TRIPs) specifically interact with the ligand binding domain of the thyroid receptor (TR). Requires the presence of thyroid hormone for its interaction.

Similarity:
Contains 1 HIT-type zinc finger.
xy-8176R    PHF8組蛋白賴氨酸去甲基化酶PHF8抗體
xy-9363R    TRAP2腫瘤壞死因子受體相關(guān)蛋白2抗體
xy-9366R    PSMD7蛋白酶調(diào)解因子7抗體
xy-2215R    phosphos-PCNA (Tyr211)磷酸化增殖細胞核抗原抗體
xy-3027R    phospho-AMPK beta 1 (Ser182)磷酸化腺苷單磷酸活化蛋白激酶β1抗體
xy-4033R    PDHB丙酮酸脫氫酶E1β亞單位抗體
xy-4032R    PHKB磷酸化酶β抗體
xy-4030R    Pancreatic Amylase胰淀粉酶抗體
xy-4034R    PDHA1丙酮酸脫氫酶α1抗體
xy-4036R    phospho-PDHA1(Ser293)磷酸化丙酮酸脫氫酶α1抗體
xy-2739R    PDPK13磷酸肌醇依賴性蛋白激酶1抗體
xy-3017R    Phospho-PDPK1(Tyr373 + Tyr376)磷酸化3磷酸肌醇依賴性蛋白激酶1抗體
xy-2740R    p53BP1p53結(jié)合蛋白1抗體
xy-3726R    phospho-PKC delta (Tyr52)磷酸化蛋白激酶C亞性D型抗體
xy-3727R    phospho-PKC delta (Thr505/507)磷酸化蛋白激酶C亞性D型抗體
xy-10399R    PKC zeta蛋白激酶C zeta 抗體
xy-7340R    PRG2嗜酸性粒細胞顆粒關(guān)鍵堿性蛋白抗體
xy-1664R    Proinsulin胰島素原抗體
xy-15501R    PCSK4原蛋白轉(zhuǎn)化酶4抗體
xy-4978R    PMCA1細胞膜鈣ATP酶1抗體
xy-4972R    PCK1磷酸烯醇丙酮酸羧激酶抗體
xy-4966R    PAPOA多聚合酶α抗體
xy-4968R    PAPOG多聚合酶g抗體
xy-11534R    QRFP神經(jīng)內(nèi)分泌肽QRFP抗體
xy-6394R    Quiescin Q6巰基氧化酶1抗體
xy-11668R    QPRT/QAPRTase喹啉酸磷酸核糖基轉(zhuǎn)移酶抗體
xy-11579R    QK1RNA結(jié)合蛋白QK1抗體
xy-11580R    RAI3維甲酸誘導蛋白3抗體
xy-11581R    RAPGEF2Rap鳥嘌呤核苷酸交換因子2抗體

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

X
該信息已收藏!
標簽:
保存成功

(空格分隔,最多3個,單個標簽最多10個字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時間回復您~
撥打電話
在線留言